Milad Pharmaceutical Consulting offers pharmacokinetic and pharmacodynamic analysis, clinical pharmacology expertise, and drug development strategy.
Development programs are streamlined by improving the efficiency of the Pre-IND phase to Phase II by applying 19 years of drug development experience coupled with pharmacokinetic and exposure response analysis.
Optimal design of the drug development program and studies ensures the availability of essential data needed to drive timely decision making to achieve business and regulatory goals.